Genenta Science S.p.A.
GNTA · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 4 ·
Latest disclosures
-
Pierluigi Paracchi: Form 4
Insider disclosure · Filed · Report period 30 Mar 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- GNTA · 36870W100 - Ordinary Shares and American Depository Shares
Company details and SEC sources
CIK 0001838716 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- GNTA on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- Olgettina, No. 58, Milan, Italy, 20132
- Incorporated in
- Italy
- Former names on EDGAR
- Genenta Science S.r.l. (to 19 May 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields